Skip to content

13F-HR filed by Davide Leone & Partners Investment Co Ltd.

Davide Leone & Partners Investment Co Ltd. filed this 13F-HR for the quarter ended 2019-09-30, filed 2019-11-14, with 12 holding rows worth $556,917,000.

Accession
0001172661-19-002239
Filed
2019-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2019

A holdings report, 12 entries on the cover page, a total value of $556,917,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $556,917,000 with VALUE read as thousands by filing date, 13F file number 028-19524. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ALTABA INC021346101COM5,446,180$106,092,000thousands by filing date
CELGENE CORP151020104COM1,008,000$100,094,000thousands by filing date
AT&T Inc00206R102COM2,256,331$85,380,000thousands by filing date
BLACKBERRY LTD COM09228F103Stock10,719,892$56,279,000thousands by filing date
ILLUMINA INC452327AH2NOTE 0.500% 6/136,961,000$49,155,000thousands by filing dateprincipal
ZAYO GROUP HLDGS INC COM98919V105Stock1,365,744$46,299,000thousands by filing date
SPRINT CORP85207U105COM SER 16,270,634$38,690,000thousands by filing date
BIOGEN INC COM09062X103Stock139,107$32,387,000thousands by filing date
INCYTE CORP COM45337C102Stock373,387$27,717,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM76,558$12,970,000thousands by filing date
AVAYA HLDGS CORP05351XAB7NOTE 2.250% 6/11,800,000$1,542,000thousands by filing dateprincipal
BERKSHIRE HATHAWAY INC DEL084670108CL A1$312,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001172661-19-002239this filing2019-11-14acceptance time not in the bulk data set